Cancer News

Mogamulizumab Superior to Vorinostat in Cutaneous T Cell Lymphoma (12/13/2017)

Results were recently presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta from a international comparative clinical trail evaluating mogamulizumab in patients with previously treated cutaneous T-cell lymphoma (CTCL). Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in a cancer’s genome. Once a …

Continue reading "Mogamulizumab Superior to Vorinostat in Cutaneous T Cell Lymphoma"

Opdivo® Highly Effective for Some Patients with Lymphomas (08/16/2016)

The immunotherapeutic agent, Opdivo® (nivolumab), appears to provide long-lasting anti-cancer activity among some patients who have received extensive prior therapy for both B- and T-cell lymphomas. These results were recently published in the Journal of Clinical Oncology. Lymphomas are a type of cancer that arise in immune cells. There are two main types of immune … Continue reading "Opdivo® Highly Effective for Some Patients with Lymphomas"

CAR Therapy Effective in Advanced Lymphoma (06/20/2016)

According to results of several presentations at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), chimeric antigen receptor (CAR) therapies appear to have significant anti-cancer activity among patients with different types of lymphomas. This type of treatment is continuing to produce impressive results, and is demonstrating effectiveness in several different types … Continue reading "CAR Therapy Effective in Advanced Lymphoma"